about
Therapeutic drug monitoring and pharmacogenetic study of HIV-infected ethnic Chinese receiving efavirenz-containing antiretroviral therapy with or without rifampicin-based anti-tuberculous therapyCholelithiasis and Nephrolithiasis in HIV-Positive Patients in the Era of Combination Antiretroviral TherapyPresence of Tablet Remnants of Nevirapine Extended-Release in Stools and Its Impact on Virological Outcome in HIV-1-Infected Patients: A Prospective Cohort StudyBatch Normalizer: a fast total abundance regression calibration method to simultaneously adjust batch and injection order effects in liquid chromatography/time-of-flight mass spectrometry-based metabolomics data and comparison with current calibratiA pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis.Analysis of magnolol and honokiol in biological fluids by capillary zone electrophoresis.Ion trace detection algorithm to extract pure ion chromatograms to improve untargeted peak detection quality for liquid chromatography/time-of-flight mass spectrometry-based metabolomics data.Screening and confirmation of 62 drugs of abuse and metabolites in urine by ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry.True ion pick (TIPick): a denoising and peak picking algorithm to extract ion signals from liquid chromatography/mass spectrometry data.Metabolomic analysis of complex chinese remedies: examples of induced nephrotoxicity in the mouse from a series of remedies containing aristolochic Acid.Using the matrix-induced ion suppression method for concentration normalization in cellular metabolomics studies.An on-spot internal standard addition approach for accurately determining colistin A and colistin B in dried blood spots using ultra high-performance liquid chromatography-tandem mass spectrometry.Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogeneFast Versus Slow Strategy of Switching Patients With Schizophrenia to Aripiprazole From Other Antipsychotics.A matrix-induced ion suppression method to normalize concentration in urinary metabolomics studies using flow injection analysis electrospray ionization mass spectrometry.Development and validation of a high-performance liquid chromatography-fluorescence detection method for the accurate quantification of colistin in human plasma.Using sweeping-micellar electrokinetic chromatography to determine voriconazole in patient plasma.Metabolomics of ginger essential oil against alcoholic fatty liver in mice.Plasma metabolomic profiles predict near-term death among individuals with lower extremity peripheral arterial disease.Using a postcolumn-infused internal standard for correcting the matrix effects of urine specimens in liquid chromatography-electrospray ionization mass spectrometry.Rapid analysis of melamine in infant formula by sweeping-micellar electrokinetic chromatography.Simultaneous quantification of antimicrobial agents for multidrug-resistant bacterial infections in human plasma by ultra-high-pressure liquid chromatography-tandem mass spectrometry.Using precursor ion scan of 184 with liquid chromatography-electrospray ionization-tandem mass spectrometry for concentration normalization in cellular lipidomic studies.A novel aerosol-mediated drug delivery system for inner ear therapy: intratympanic aerosol methylprednisolone can attenuate acoustic trauma.Development of an LC-MS/MS method with protein G purification strategy for quantifying bevacizumab in human plasma.Association of blood lead and mercury with estimated GFR in herbalists after the ban of herbs containing aristolochic acids in Taiwan.Sensitive screening of abused drugs in dried blood samples using ultra-high-performance liquid chromatography-ion booster-quadrupole time-of-flight mass spectrometry.Lipophagy prevents activity-dependent neurodegeneration due to dihydroceramide accumulation in vivo.Development of a Postcolumn Infused-Internal Standard Liquid Chromatography Mass Spectrometry Method for Quantitative Metabolomics Studies.Identification of potential sphingomyelin markers for the estimation of hematocrit in dried blood spots via a lipidomic strategy.Quantification of target analytes in various biofluids using a postcolumn infused-internal standard method combined with matrix normalization factors in liquid chromatography-electrospray ionization mass spectrometry.Rapid quantification of glutaminase 2 (GLS2)-related metabolites by HILIC-MS/MS.Estimation and Correction of the Blood Volume Variations of Dried Blood Spots Using a Postcolumn Infused-Internal Standard Strategy with LC-Electrospray Ionization-MS.Using water plug-assisted analyte focusing by micelle collapse in combination with microemulsion electrokinetic chromatography for analyzing phthalate esters.Chromaligner: a web server for chromatogram alignment.Development and application of a comparative fatty acid analysis method to investigate voriconazole-induced hepatotoxicity.Determination of bisbenzylisoquinoline alkaloids by high-performance liquid chromatography (II)Metabolomic characterization of laborers exposed to welding fumesPersistence of mutant isocitrate dehydrogenase in patients with acute myeloid leukemia in remissionRapid and sensitive determination of posaconazole in patient plasma by capillary electrophoresis with field-amplified sample stacking
P50
Q28539806-87FCEBCB-7AFE-499E-8522-334D48E7064FQ28547869-782B92CF-0963-4645-AD09-322EB46A2B2AQ28550278-365D5FA5-DB5A-4C0E-B739-12CF4B90E88EQ30581700-C8DCAAD2-393A-4D91-B5EC-45C597925BBCQ30641737-3153A8F8-E7F2-4F51-A227-5B2AFFEC44A1Q30829250-0C4DFD7B-9E8C-4109-8BB5-14E9BFA7C441Q30886105-6B78AB3F-A05E-4A6B-A857-7CC855AA12FFQ34374699-59543BC1-D6E6-4136-9F87-A28FED42B00AQ34573371-CA1CF211-6491-4735-B9FE-5769D33E9A19Q36766173-4D59249B-7750-4FEB-ACAC-3A2280CD720BQ38836131-9E06AC7B-5F88-4294-9FA7-B42EA215229AQ40079058-47E22097-EFAE-404A-913E-54E5DA4EF3F2Q40799765-BA12DAFC-866E-4CDA-B1E1-AD20CBB08527Q41196955-1C8157E0-4C7A-4B1A-895F-90A5A1C247D2Q41319518-64037378-B72B-4E08-9C2E-01D127D54115Q41544691-1A22C458-16A6-497E-9DB7-B85647187E47Q42985025-DF3B808F-1319-42F5-8160-93E699D70AD4Q44666269-2B45CB79-AA46-4932-B41F-070F25E60B1FQ45094829-7C6CB498-8515-4325-932B-03F451FC2FE4Q45174145-54E7508C-CC3B-40D9-8136-E982BFDD2710Q45949585-3D41C668-971D-4A69-BF6C-214983931CDFQ45949963-B1DA10B9-B6E2-41F2-9235-C1CD7E657DE9Q46374610-672E1634-DB6F-46BA-B3BC-98B679DC30E1Q46485342-3BB6417E-CE94-4D42-93BD-5A4FBDF4CD24Q47722523-1628125F-8FB2-4E2A-9D64-65EE293D6310Q47754870-66744C09-6427-4056-99B2-549F04FB7E5CQ47976717-5F9386C7-E950-4E1A-BE53-7AFAF23013D8Q48141984-1A7497FB-6991-4F81-88A4-3F1B8CECA6AAQ48372971-71A27A07-1A30-482D-87EC-4300B0DDDA2EQ48544626-D5103101-FA1D-4533-8DA0-8DD623CA8294Q48661072-D36E838C-4DDA-4D6C-A894-E9800F54CA50Q49380825-6CCAE459-D66E-4830-B8CA-FF32174612A2Q50850253-DE92D137-631A-4FF8-9373-AFD38544D92DQ50862707-4177CB04-C337-48FE-AD4E-A20CAE741957Q51686183-8D778E88-19A8-46BA-9629-3ECD7E958A5AQ53466711-C2CA574E-4381-4E38-8523-63580521932FQ74351864-4916B85D-83A0-4BDB-924A-8E9BB33FA317Q83367177-49FFD839-825B-43B5-B49E-1A84C8F6A120Q84773113-35601936-03CE-4AF7-8D72-90E03304B7D7Q84840306-5E035746-EA13-494D-92C8-6AC9B6312EF6
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ching-Hua Kuo
@ast
Ching-Hua Kuo
@en
Ching-Hua Kuo
@es
Ching-Hua Kuo
@nl
type
label
Ching-Hua Kuo
@ast
Ching-Hua Kuo
@en
Ching-Hua Kuo
@es
Ching-Hua Kuo
@nl
prefLabel
Ching-Hua Kuo
@ast
Ching-Hua Kuo
@en
Ching-Hua Kuo
@es
Ching-Hua Kuo
@nl
P106
P31
P496
0000-0001-5722-0360